Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus
Under a Creative Commons license
open archive
Key words
basic (laboratory) research/science
clinical research/practice
cellular biology
immunosuppression/immune modulation
immune regulation
tolerance
metabolism/metabolite
Abbreviations
anti-IL2R
IL-2 receptor blocker
AR
acute rejection
ATG
anti–thymocyte globulin
CI
confidence interval
CIT
cold ischemic time
CMS
Centers for Medicare and Medicaid Services
CMV
cytomegalovirus
DCD
donation after cardiac death
DGF
delayed graft function
ECD
expanded criteria donor
ESRD
end-stage renal disease
HBsAg
hepatitis B surface antigen
HCV
hepatitis C virus
HIV+
human immunodeficiency virus positive
HIV–
human immunodeficiency virus uninfected
ICD-9
International Classification of Diseases, Ninth Revision
IPTW
inverse probability of treatment weight
KT
kidney transplant
LOS
length of stay
NIH
National Institutes of Health
OPTN
Organ Procurement and Transplantation Network
PRA
panel reactive antibody
SD
standard deviation
SRTR
Scientific Registry of Transplant Recipients
UTI
urinary tract infection
wHR
weighted hazard ratio
wRR
weighted relative risk
Cited by (0)
Copyright © 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.